Adoptive cell therapy for the treatment of patients with metastatic melanomaSteven A. Rosenberg(National Cancer Institute), Mark E. Dudley(National Cancer Institute)Current Opinion in ImmunologyMarch 23, 200910.1016/j.coi.2009.03.002Cited by 590SaveCiteExport RISWatch citationsAbstractRelated PapersA Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaPierre van der Bruggen, Catia Traversari, Patrick Chomez et al.|Science|1991|3.5kCancer immunotherapy: moving beyond current vaccinesSteven A. Rosenberg, James C. Yang, Nicholas P. Restifo|Nature Medicine|2004|3kCancer Regression in Patients After Transfer of Genetically Engineered LymphocytesRichard A. Morgan, Mark E. Dudley, John R. Wunderlich et al.|Science|2006|2.6kAdoptive cell transfer: a clinical path to effective cancer immunotherapySteven A. Rosenberg, Nicholas P. Restifo, James C. Yang et al.|Nature reviews. Cancer|2008|1.7kSpecific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.Zelig Eshhar, Tova Waks, G. Gross et al.|Proceedings of the National Academy of Sciences|1993|1.6k